PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
| Data generation and assessment | ARN | Regulatory risk management | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Proquinazid | 606-168-7 | 189278-12-4 | - | - | - | - | - | 2 | - | - | - | Details |
|
Protein hydrolyzates, animal
Substance obtained by acidic, alkaline, or enzymatic hydrolysis of mixed animals composed primarily of amino acids, peptides, and proteins. It may contain impurities consisting chiefly of carbohydrates and lipids along with smaller quantities of miscellaneous organic substances of biological origin.
|
309-203-1 | 100085-61-8 | - | - | 1 | - | - | - | - | - | - | Details |
| prothioconazole (ISO); 2-[2-(1-chlorocyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl]-2,4-dihydro-3H-1,2,4-triazole-3-thione | 605-841-2 | 178928-70-6 | - | - | - | - | - | 1 | - | - | - | Details |
| Proxan-sodium | 205-443-5 | 140-93-2 | - | - | 1 | - | - | - | - | - | - | Details |
| PURAM | 434-000-0 | - | - | - | - | - | 1 | - | - | - | - | Details |
| Purine-2(3H),6(1H)-dione | 200-718-6 | 69-89-6 | - | - | - | - | 1 | - | - | - | - | Details |
| pymetrozine (ISO); (E)-4,5-dihydro-6-methyl-4-(3-pyridylmethyleneamino)-1,2,4-triazin-3(2H)-one | 602-927-1 | 123312-89-0 | - | - | - | - | - | 1 | - | - | - | Details |
| Pyraclostrobin | 605-747-1 | 175013-18-0 | - | - | - | - | - | 1 | - | - | - | Details |
| Pyrazole | 206-017-1 | 288-13-1 | - | - | - | - | 1 | - | - | - | - | Details |
| pyridalyl (ISO); 2,6-dichloro-4-(3,3-dichloroallyloxy)phenyl 3-[5-(trifluoromethyl)-2-pyridyloxy]propyl ether | 605-845-4 | 179101-81-6 | - | - | - | - | - | 1 | - | - | - | Details |